Avita Medical (ASX:AVH) Surges Over 11% on Strong Growth Outlook

2 min read | February 14, 2025 02:21 PM AEDT | By Team Kalkine Media

Highlights 

  • Avita Medical (AVH) shares jump over 11% following revenue guidance announcement. 
  • Company projects a 55-65% growth in full-year 2024 commercial revenue. 
  • Net loss widens due to increased operating expenses. 

Avita Medical (ASX:AVH) saw a sharp rise in its share price, gaining 11.6% on Friday after unveiling an optimistic revenue forecast for 2025. The company, known for its innovative wound care solutions, projected commercial revenues between $100 million and $106 million USD ($158.16 million to $167.65 million AUD). 

This updated outlook signals a significant growth of 55% to 65% in full-year 2024 revenue, reflecting the increasing demand for its RECELL GO product. Avita Medical (ASX:AVH) has been expanding its market presence, with both new and existing customers contributing to the rise in adoption. 

For the latest financial year, commercial revenue reached $64 million USD, representing a 29% increase compared to the previous year. The company attributes this growth to a strong uptake of its technology, which is designed to enhance the healing process for patients with severe burns and other skin injuries. 

Despite this impressive revenue expansion, Avita Medical (ASX:AVH) reported a net loss of $61.8 million USD, up from $35.4 million USD in the prior year. The increased losses were attributed to higher operating expenses and lower other income. As the company invests in research, development, and market expansion, these costs have impacted its bottom line. 

Looking ahead, Avita Medical (ASX:AVH) remains focused on further commercializing its products and capitalizing on the growing demand for advanced wound care solutions. The strong revenue projections indicate confidence in its market positioning, while the rise in costs highlights the investments being made to support future growth. 

With its latest revenue guidance and the expanding adoption of RECELL GO, Avita Medical (AVH) continues to capture investor attention. The recent surge in share price reflects market optimism surrounding its growth trajectory and potential for long-term success in the healthcare sector. 


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.